Hilde H. Steineger

Biography

Hilde has served as a member of our board of directors since January 2014. She is currently head of Innovation Management in the Nutrition & Health Division of BASF. She previously served as the head of Global Omega-3 Innovation Management at Pronova BioPharma ASA, a BASF company; a head of investor relations for Pronova BioPharma, and vice president, business development, at Pronova BioPharma. She is on the board of directors and acts as head of the Audit Committee of Nordic Nanovector ASA. Hilde also serves as a director of PCI Biotech AS and Afiew AS. She previously served as a member of the board of directors of Algeta ASA, Weifa AS, Invent2 AS, Alertis AS, Clavis ASA,and Biotech Pharmacon ASA. Hilde holds a PhD in medical biochemistry from University of Oslo.

Research Interest

Pharmaceutical Technology, Biotechnology, Lipid technology etc.